Clinical Trials

topic · knowledge/clinical-trials
DOC.
knowledge/clinical-trials
REV.
901 evt
DATE.
05-JUN-2026
SCOPE.
custom
§01

about

Recently updated registered clinical trials (ClinicalTrials.gov).

§02

recent events

LIVElast event 0s ago0 evt / 1h

showing 10 of 856 events in this window (901 total on topic). adjust the range or clear it with ALL.

range
iso 8601 utc
iso 8601 utc
01Clinical Evaluation of Two Fissure Sealants (Resin Based Versus Giomer Fissure Sealants) on Molar Incisor Hypominerlisation Affected Permanent Molars (RCT)COMPLETED · NA · Molar Hypomineralization, Incisor{"url":"https://clinicaltrials.gov/study/NCT07732790","title":"Clinical Evaluati…
EVENT. cms63i6mID. cms63i6mzajp7kh0cxptax24bSRC. key:cmpxakb6
{
  "url": "https://clinicaltrials.gov/study/NCT07732790",
  "title": "Clinical Evaluation of Two Fissure Sealants (Resin Based Versus Giomer Fissure Sealants) on Molar Incisor Hypominerlisation Affected Permanent Molars (RCT)",
  "nct_id": "NCT07732790",
  "phases": [
    "NA"
  ],
  "source": "clinicaltrials.gov",
  "status": "COMPLETED",
  "conditions": [
    "Molar Hypomineralization, Incisor",
    "Fissure Sealant",
    "Resin Based Sealers"
  ],
  "enrollment": 22,
  "study_type": "INTERVENTIONAL",
  "lead_sponsor": "National Research Centre, Egypt",
  "published_at": "2026-07-29T00:00:00.000Z",
  "interventions": [
    {
      "name": "Resin based fissure sealant (Fisseal)",
      "type": "OTHER"
    },
    {
      "name": "Giomer based fissure sealant ( Beautisealant)",
      "type": "OTHER"
    }
  ],
  "sponsor_class": "OTHER",
  "official_title": "Clinical Evaluation of Resin Based Versus Giomer Fissure Sealants on MIH Affected Permanent Molars (RCT)",
  "first_posted_at": "2026-07-29T00:00:00.000Z"
}
02Intervention For Adolescents and Young Adults (AYAs) With Cancer Risk SyndromesACTIVE_NOT_RECRUITING · NA · Cancer Risk Syndrome{"url":"https://clinicaltrials.gov/study/NCT04323774","title":"Intervention For …
EVENT. cms63i62ID. cms63i62aajp5kh0c6yj97mdtSRC. key:cmpxakb6
{
  "url": "https://clinicaltrials.gov/study/NCT04323774",
  "title": "Intervention For Adolescents and Young Adults (AYAs) With Cancer Risk Syndromes",
  "nct_id": "NCT04323774",
  "phases": [
    "NA"
  ],
  "source": "clinicaltrials.gov",
  "status": "ACTIVE_NOT_RECRUITING",
  "conditions": [
    "Cancer Risk Syndrome"
  ],
  "enrollment": 115,
  "study_type": "INTERVENTIONAL",
  "lead_sponsor": "Dana-Farber Cancer Institute",
  "published_at": "2026-07-29T00:00:00.000Z",
  "interventions": [
    {
      "name": "AYA-RISE Adolescents and Young Adults Risk Information and Screening Education",
      "type": "BEHAVIORAL"
    },
    {
      "name": "Standard clinical visit for genetic counseling",
      "type": "BEHAVIORAL"
    }
  ],
  "sponsor_class": "OTHER",
  "official_title": "AYA-RISE: Refining a Scalable, Patient- and Family-centered Intervention to Improve Cancer Risk Communication and Decision-making Among Adolescents and Young Adults With Cancer Risk Syndromes",
  "first_posted_at": "2020-03-27T00:00:00.000Z"
}
03Healthy Lifestyles: A Home Based Physical Activity Intervention in Persons Living With HIVCOMPLETED · NA · HIV-1-infection{"url":"https://clinicaltrials.gov/study/NCT05896852","title":"Healthy Lifestyle…
EVENT. cms63i5hID. cms63i5h6ajp3kh0cjvn6kxthSRC. key:cmpxakb6
{
  "url": "https://clinicaltrials.gov/study/NCT05896852",
  "title": "Healthy Lifestyles: A Home Based Physical Activity Intervention in Persons Living With HIV",
  "nct_id": "NCT05896852",
  "phases": [
    "NA"
  ],
  "source": "clinicaltrials.gov",
  "status": "COMPLETED",
  "conditions": [
    "HIV-1-infection",
    "Metabolic Syndrome"
  ],
  "enrollment": 40,
  "study_type": "INTERVENTIONAL",
  "lead_sponsor": "Georgetown University",
  "published_at": "2026-07-29T00:00:00.000Z",
  "interventions": [
    {
      "name": "physical activity",
      "type": "BEHAVIORAL"
    }
  ],
  "sponsor_class": "OTHER",
  "official_title": "Healthy Lifestyles: A Home Based Physical Activity Intervention in Persons Living With HIV",
  "first_posted_at": "2023-06-09T00:00:00.000Z"
}
04RELATIONSHIP BETWEEN ULTRASONOGRAPHIC QUADRICEPS MUSCLE THICKNESS AND SARCOPENIA MARKERS (HANDGRIP STRENGTH, SARC-F) AND KINESIOPHOBIA IN STROKE PATIENTSRECRUITING · Stroke{"url":"https://clinicaltrials.gov/study/NCT07734506","title":"RELATIONSHIP BETW…
EVENT. cms63i4xID. cms63i4x0ajp1kh0cu62o0eq0SRC. key:cmpxakb6
{
  "url": "https://clinicaltrials.gov/study/NCT07734506",
  "title": "RELATIONSHIP BETWEEN ULTRASONOGRAPHIC QUADRICEPS MUSCLE THICKNESS AND SARCOPENIA MARKERS (HANDGRIP STRENGTH, SARC-F) AND KINESIOPHOBIA IN STROKE PATIENTS",
  "nct_id": "NCT07734506",
  "phases": [],
  "source": "clinicaltrials.gov",
  "status": "RECRUITING",
  "conditions": [
    "Stroke",
    "Sarcopenia",
    "Kinesiophobia"
  ],
  "enrollment": 50,
  "study_type": "OBSERVATIONAL",
  "lead_sponsor": "Istanbul Physical Medicine Rehabilitation Training and Research Hospital",
  "published_at": "2026-07-29T00:00:00.000Z",
  "interventions": [],
  "sponsor_class": "OTHER_GOV",
  "official_title": "EVALUATION OF THE RELATIONSHIP BETWEEN ULTRASONOGRAPHICALLY MEASURED QUADRICEPS MUSCLE THICKNESS AND SARCOPENIA MARKERS (HANDGRIP STRENGTH, SARC-F) AND KINESIOPHOBIA IN STROKE PATIENTS",
  "first_posted_at": "2026-07-29T00:00:00.000Z"
}
05A Neuroimaging Study of Open-label Placebo in Depressed AdolescentsTERMINATED · NA · Depression{"url":"https://clinicaltrials.gov/study/NCT04201106","title":"A Neuroimaging St…
EVENT. cms63i4cID. cms63i4coajozkh0cz4wilu38SRC. key:cmpxakb6
{
  "url": "https://clinicaltrials.gov/study/NCT04201106",
  "title": "A Neuroimaging Study of Open-label Placebo in Depressed Adolescents",
  "nct_id": "NCT04201106",
  "phases": [
    "NA"
  ],
  "source": "clinicaltrials.gov",
  "status": "TERMINATED",
  "conditions": [
    "Depression"
  ],
  "enrollment": 16,
  "study_type": "INTERVENTIONAL",
  "lead_sponsor": "University of California, San Francisco",
  "published_at": "2026-07-29T00:00:00.000Z",
  "interventions": [
    {
      "name": "Open Label Placebo with Rationale",
      "type": "BEHAVIORAL"
    },
    {
      "name": "Open Label Placebo without Rationale",
      "type": "BEHAVIORAL"
    }
  ],
  "sponsor_class": "OTHER",
  "official_title": "A Neuroimaging Study of Open-label Placebo in Depressed Adolescents",
  "first_posted_at": "2019-12-17T00:00:00.000Z"
}
06Humacyte Acellular Tissue Engineered Vessel (ATEV) in Patients With Vascular TraumaCOMPLETED · PHASE2/PHASE3 · Trauma{"url":"https://clinicaltrials.gov/study/NCT03005418","title":"Humacyte Acellula…
EVENT. cms63i3sID. cms63i3sfajoxkh0cva0cag50SRC. key:cmpxakb6
{
  "url": "https://clinicaltrials.gov/study/NCT03005418",
  "title": "Humacyte Acellular Tissue Engineered Vessel (ATEV) in Patients With Vascular Trauma",
  "nct_id": "NCT03005418",
  "phases": [
    "PHASE2",
    "PHASE3"
  ],
  "source": "clinicaltrials.gov",
  "status": "COMPLETED",
  "conditions": [
    "Trauma",
    "Vascular System Injury"
  ],
  "enrollment": 72,
  "study_type": "INTERVENTIONAL",
  "lead_sponsor": "Humacyte, Inc.",
  "published_at": "2026-07-29T00:00:00.000Z",
  "interventions": [
    {
      "name": "Acellular Tissue Engineered Vessel (ATEV)",
      "type": "BIOLOGICAL"
    }
  ],
  "sponsor_class": "INDUSTRY",
  "official_title": "A Phase 2/3 Study for the Evaluation of Safety and Efficacy of Humacyte's ATEV for Vascular Replacement or Reconstruction in Patients With Life or Limb-threatening Vascular Trauma",
  "first_posted_at": "2016-12-29T00:00:00.000Z"
}
07Treatment of Residual Refraction Errors 6 Months After Trifocal IOL Implantation With Relex-SmileENROLLING_BY_INVITATION · NA · Pseudophakia{"url":"https://clinicaltrials.gov/study/NCT04712318","title":"Treatment of Resi…
EVENT. cms63i37ID. cms63i37zajovkh0cvcur968ySRC. key:cmpxakb6
{
  "url": "https://clinicaltrials.gov/study/NCT04712318",
  "title": "Treatment of Residual Refraction Errors 6 Months After Trifocal IOL Implantation With Relex-Smile",
  "nct_id": "NCT04712318",
  "phases": [
    "NA"
  ],
  "source": "clinicaltrials.gov",
  "status": "ENROLLING_BY_INVITATION",
  "conditions": [
    "Pseudophakia",
    "Myopia",
    "Hyperopia"
  ],
  "enrollment": 130,
  "study_type": "INTERVENTIONAL",
  "lead_sponsor": "Eye Hospital Pristina Kosovo",
  "published_at": "2026-07-29T00:00:00.000Z",
  "interventions": [
    {
      "name": "Relex Smile",
      "type": "PROCEDURE"
    },
    {
      "name": "Relex smile with fresh corneal lenticule implantation",
      "type": "PROCEDURE"
    }
  ],
  "sponsor_class": "OTHER",
  "official_title": "Succesful Treatment of Residual Refraction Errors (Myopic and Hyperopic) 6 Months After Trifocal IOL Implantation With Relex-Smile",
  "first_posted_at": "2021-01-15T00:00:00.000Z"
}
08Evaluation of the Effectiveness of Manual Lymphatic Drainage in Young Women With Primary DysmenorrheaCOMPLETED · NA · Dysmenorrhea Primary{"url":"https://clinicaltrials.gov/study/NCT07378475","title":"Evaluation of the…
EVENT. cms63i2nID. cms63i2niajotkh0cuzd7eon5SRC. key:cmpxakb6
{
  "url": "https://clinicaltrials.gov/study/NCT07378475",
  "title": "Evaluation of the Effectiveness of Manual Lymphatic Drainage in Young Women With Primary Dysmenorrhea",
  "nct_id": "NCT07378475",
  "phases": [
    "NA"
  ],
  "source": "clinicaltrials.gov",
  "status": "COMPLETED",
  "conditions": [
    "Dysmenorrhea Primary"
  ],
  "enrollment": 20,
  "study_type": "INTERVENTIONAL",
  "lead_sponsor": "Camilo Jose Cela University",
  "published_at": "2026-07-29T00:00:00.000Z",
  "interventions": [
    {
      "name": "Manual Lymphatic Drainage (MLD)",
      "type": "OTHER"
    }
  ],
  "sponsor_class": "OTHER",
  "official_title": "Evaluation of the Effectiveness of Manual Lymphatic Drainage in Young Women With Primary Dysmenorrhea",
  "first_posted_at": "2026-01-30T00:00:00.000Z"
}
09Isa-VRdlite for of Frail and/or Much Older Patients With High Risk Newly Diagnosed Multiple Myeloma Base on Circulating Plasma CellsNOT_YET_RECRUITING · PHASE2/PHASE3 · Multiple Myeloma{"url":"https://clinicaltrials.gov/study/NCT07732712","title":"Isa-VRdlite for o…
EVENT. cms63i23ID. cms63i233ajorkh0cbisph1c2SRC. key:cmpxakb6
{
  "url": "https://clinicaltrials.gov/study/NCT07732712",
  "title": "Isa-VRdlite for of Frail and/or Much Older Patients With High Risk Newly Diagnosed Multiple Myeloma Base on Circulating Plasma Cells",
  "nct_id": "NCT07732712",
  "phases": [
    "PHASE2",
    "PHASE3"
  ],
  "source": "clinicaltrials.gov",
  "status": "NOT_YET_RECRUITING",
  "conditions": [
    "Multiple Myeloma"
  ],
  "enrollment": 15,
  "study_type": "INTERVENTIONAL",
  "lead_sponsor": "The Affiliated People's Hospital of Ningbo University",
  "published_at": "2026-07-29T00:00:00.000Z",
  "interventions": [
    {
      "name": "Isatuximab",
      "type": "DRUG"
    },
    {
      "name": "VRD",
      "type": "DRUG"
    }
  ],
  "sponsor_class": "OTHER_GOV",
  "official_title": "Isa-VRdlite for of Frail and/or Much Older Patients With High Risk Newly Diagnosed Multiple Myeloma Base on Circulating Plasma Cells",
  "first_posted_at": "2026-07-29T00:00:00.000Z"
}
10Effects of Sirolimus on Asymptomatic ApoE4 CarriersNOT_YET_RECRUITING · PHASE1 · Genetic Predisposition to Disease{"url":"https://clinicaltrials.gov/study/NCT07728175","title":"Effects of Siroli…
EVENT. cms63i1iID. cms63i1icajopkh0cw5o0vkofSRC. key:cmpxakb6
{
  "url": "https://clinicaltrials.gov/study/NCT07728175",
  "title": "Effects of Sirolimus on Asymptomatic ApoE4 Carriers",
  "nct_id": "NCT07728175",
  "phases": [
    "PHASE1"
  ],
  "source": "clinicaltrials.gov",
  "status": "NOT_YET_RECRUITING",
  "conditions": [
    "Genetic Predisposition to Disease",
    "Healthy Volunteer",
    "APOE-4 Positive"
  ],
  "enrollment": 225,
  "study_type": "INTERVENTIONAL",
  "lead_sponsor": "University of Missouri-Columbia",
  "published_at": "2026-07-29T00:00:00.000Z",
  "interventions": [
    {
      "name": "Sirolimus (rapamycin)",
      "type": "DRUG"
    },
    {
      "name": "Placebo",
      "type": "DRUG"
    }
  ],
  "sponsor_class": "OTHER",
  "official_title": "Effects of Sirolimus on Middle Aged Asymptomatic ApoE4 Carriers",
  "first_posted_at": "2026-07-27T00:00:00.000Z"
}
showing 1–10 of 856older →
§03

subscribe

three pathways carry every event on this topic. pick the one that fits your agent.

GETrss feed
any reader · no auth
https://api.callsign.sh/v1/public/channels/knowledge/topics/clinical-trials/feed.xml
GETjson pull
poll on your schedule · optional since/until
https://api.callsign.sh/v1/public/channels/knowledge/topics/clinical-trials.json
POSTwebhook
push delivery · one POST per event
log in to subscribe →
subscribe by reader, by pull loop, or by webhook above